IMAX Raises 2026 Box-Office and Margin Outlook After Strong Q3

IMAX Corp. (IMAX) raised its full-year 2026 global box-office outlook to more than $1.4 billion from $1.4 billion and now expects a total adjusted EBITDA margin of about 50%, compared with its previous mid-40% forecast. The updated guidance followed a third quarter marked by sharply higher box office, revenue and adjusted earnings as demand for premium-format releases lifted operating leverage.

For the three months ended Sept. 30, revenue reached $174.6 million, up from $106.7 million a year earlier. Global IMAX box office, including China booking fees, nearly doubled to $712 million from $368 million, while gross profit increased to $126.3 million from $67.3 million. Gross margin expanded to 72.3% from 63.1%.

Total adjusted EBITDA rose to $120.9 million from $51.8 million, producing a margin of 69.3% compared with 48.6% in the prior-year quarter. Adjusted net income attributable to common shareholders was $127.9 million, or $2.21 per diluted share, versus $26.2 million, or $0.47 per share, a year earlier.

GAAP net income was $117.1 million, compared with $22.6 million in the third quarter of 2025. GAAP net income attributable to common shareholders increased to $113.8 million, or $1.96 per diluted share, from $20.7 million, or $0.37 per share. The quarter included a $43.3 million income-tax recovery, and the company said the release of a valuation allowance affected the tax treatment of its 2026 non-GAAP adjustments.

Box-office share and premium demand strengthen

For the first nine months of 2026, IMAX generated $1.26 billion in global box office, up from $947 million in the comparable 2025 period. Revenue increased to $358.8 million from $285.0 million, while total adjusted EBITDA advanced to $199.4 million from $127.8 million. The year-to-date adjusted EBITDA margin was 55.6%, compared with 44.9% a year earlier.

The company said 2026 had already become the highest-grossing box-office year in its history with two months remaining. IMAX’s global box-office market share was 4.6% through September, compared with 3.8% for full-year 2025. Its September trailing-12-month global share was 4.5%, despite the network representing less than 1% of worldwide screens.

Demand for titles produced under the Filmed for IMAX program also increased. The average domestic opening-weekend indexing for those releases reached 18.6% through September, up from 15.3% in 2025. IMAX expects at least 12 Filmed for IMAX titles in 2027, along with four releases using 70mm film prints.

The company is also broadening its content mix beyond Hollywood releases. More than 70 local-language titles are expected to play on the network in 2026. Local-language films represented about 9% of year-to-date global box office, while Japanese release “Godzilla Minus Zero” delivered what IMAX described as its highest opening day for a Japanese film. The company is also working with streaming platforms on theatrical launches and live events, including an Apple partnership to stream five Formula 1 races across at least 50 U.S. IMAX locations in 2026.

Network pipeline supports expansion

IMAX installed 89 systems and signed agreements for 79 systems during the first nine months of 2026. As of Sept. 30, its commercial network included 1,820 locations across 91 countries and territories, with 409 systems in backlog, comprising 257 new systems and 152 upgrades.

The company maintained its full-year installation forecast of 160 to 175 systems. It expects an approximately 45%/55% mix between sales and joint revenue-sharing arrangements, and an even split between new systems and upgrades.

IMAX said more than half of its target market remains available for expansion. Rest-of-world markets outside the domestic market and Greater China were 36% penetrated, according to the presentation, while the international commercial network excluding China has expanded 40% since 2019.

The fourth-quarter slate is expected to include “The Further Misadventures of Cliff Booth,” “Dune: Part Three” and “Godzilla Minus Zero.” The release schedule reflects studio plans as of Nov. 5 and remains subject to change.

Cash flow and longer-term targets

Operating cash flow totaled a record $122.1 million for the first nine months, up 25% from $97.7 million a year earlier. Free cash flow increased to $100.3 million from $62.9 million, representing roughly 50% conversion from adjusted EBITDA.

IMAX ended September with $207.9 million in cash and total liquidity of $640.8 million. Total debt stood at $250.5 million, leaving net debt of $42.6 million and a net-debt-to-trailing-12-month total adjusted EBITDA ratio of 0.18 times. The company repurchased $13.7 million of shares during the first nine months and had $251 million remaining under its authorization.

Using 2025 as a base year, management is targeting a high-single-digit to low-double-digit revenue compound annual growth rate through 2028. It also expects adjusted EPS to grow at twice the rate of revenue, free-cash-flow conversion to exceed 50% by 2028 and adjusted EBITDA margin to reach about 50% in 2026 and continue growing.

Those expectations remain exposed to changes in film-release timing and performance, exhibitor demand and payment capacity, currency movements, competition and conditions in the commercial exhibition industry. IMAX also identified risks tied to its China operations, international trade and geopolitical tensions, its ability to convert backlog into revenue and cash flow, and the execution of new content and technology initiatives.